Physician profile
Junuk Kim
NPI 1497917553
$5,562.27
in general payments reported to CMS, 2019-2025
13 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $13.45 · 2021: $127 · 2022: $997 · 2023: $596 · 2024: $2,434 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,813 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,812.50 |
| Food and Beverage | $487.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $3,702.93 | 2022-2024 | Voyant Fine Fusion Device |
| Intuitive Surgical, INC. | $1,130.59 | 2019-2022 | |
| Tela Bio, INC. | $301.28 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mimedx Group, INC. | $146.02 | 2025 | |
| Medtronic, INC. | $104.09 | 2021 | |
| Ethicon US, LLC | $36.14 | 2019 | |
| Coloplast Corp | $32.31 | 2022-2024 | |
| Inspire Medical Systems, INC. | $24.08 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $22.43 | 2021 | |
| Acell, INC. | $18.11 | 2019 | |
| Allergan, INC. | $16.50 | 2019 | |
| Thd America, INC. | $14.34 | 2023 | |
| Convatec INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junuk Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.